Mark Gelernt is a Cardiology physician affiliated with The Heart House.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →
Clinical & industry
trials, payments and federal fundingIndustry payments
34 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- NovartisProgram year20253 paymentsResearch$217,912openpaymentsdata.cms.gov ↗
- AstraZenecaProgram year20251 paymentResearch
- Novartis Pharmaceuticals CorporationProgram year202528 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Similar KOLs
Other experts from the same institution or the same specialty.
Dilip Viswanath, MD
The Heart House
Sanford Gips, MD
The Heart House
Steven Levi, MD
The Heart House
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Martin Leon, MD
Columbia University Irving Medical Center
Gregg Fonarow, MD
Ronald Reagan UCLA Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”